凝固酶阴性葡萄球菌耐药机制及其干预研究进展

Progress of research on drug resistance mechanisms of coagulase-negative Staphylococci and intervention measures

  • 摘要: 凝固酶阴性葡萄球菌(CoNS)是一类不具备凝固酶产生能力的革兰阳性球菌, 这一特性是其与金黄色葡萄球菌的关键区别, CoNS广泛分布于自然环境中, 常见于皮肤、黏膜及其他宿主相关组织。近年来, CoNS已成为医院获得性感染的重要致病因素之一, 在免疫功能受损的患者中尤为显著。虽然CoNS的致病性通常被认为低于凝固酶阳性葡萄球菌, 但随着植入性医疗器械的普及和抗菌药物的广泛使用, 其耐药性问题日益突出, 已引起临床的高度重视。因此, 本文通过对PubMed、Embase、中国知网等数据库进行检索, 揭示CoNS耐药机制, 旨在推动针对耐药性细菌的新药及新兴诊疗措施研发, 为全球抗生素耐药问题的解决提供科学依据。

     

    Abstract: Coagulase-negative Staphylococci (CoNS) are a group of gram-positive cocci incapable of producing coagulase, which distinguishes them from Staphylococcus aureus. CoNS are widely distributed in natural environment and are commonly found on skin, mucous membranes and other host-associated tissues. In recent years, CoNS have become one of the significant pathogenic factors for hospital-associated infections and have been particularly prevalent among the patients with impaired immune function. Although the pathogenicity of CoNS is generally considered lower than that of coagulase-positive Staphylococci, the widespread use of implanted medical devices and extensive use of antibiotics has led to increasingly serious problems of drug resistance, which has attached great importance to the hospital. The databases such as PubMed, Embase and CNKI were retrieved to reveal the drug resistance mechanisms of CoNS, aiming to push forward the research and development of new drugs against drug-resistant bacteria and emerging diagnosis and treatment measures and provide scientific bases for solving the problems of antibiotics resistance around the globe.

     

/

返回文章
返回